Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 42

Sort by

Sort Order Select

Journal Articles

Decidua Stromal Cell (DSCs), As an Alternative Treatment for Acute Inflammatory Diseases

Britt Gustafsson, Olle Ringden, Behnam Sadeghi

Blood (2022) 140 (Supplement 1): 12720–12721.

https://doi.org/10.1182/blood-2022-156585

Published: 2022

Journal Articles

The Use of Placenta-Derived Decidua Stromal Cells for Treatment of Severe Acute Gastrointestinal Graft-Versus-Host-Disease in Adults and Children

Sadeghi Behnam, PhD MD, Remberger Mats, PhD, Per Frisk, MD PhD, Britt-Marie Frost, MD PhD, Olle Ringden, Professor, Britt Gustafsson, MD PhD

Blood (2019) 134 (Supplement_1): 4456.

https://doi.org/10.1182/blood-2019-122674

Published: 2019

Journal Articles

Comparable Results of Autologous and Allogeneic Hematopoietic Stem Cell Transplantation for Adult Patients with Philadelphia-Positive Acute Lymphoblastic Leukemia in First Complete Molecular Remission: An Analysis By the Acute Leukemia Working Party of the EBMT

Sebastian Giebel, Myriam Labopin, MD, Michael Potter, Xavier Poiré, MD, Henrik Sengeloev, MD, Gerard Socié, MD PhD, Anne Huynh, MD, Boris V Afanasyev, Professor, Urs Schanz, MD, Olle Ringden, Peter Kalhs, MD, Dietrich W. Beelen, Prof. Dr. MD, Antonio M. Campos, MD, Tamás Masszi, MD PhD, Mohamad Mohty, MD PhD, Arnon Nagler*, MD

Blood (2016) 128 (22): 512.

https://doi.org/10.1182/blood.V128.22.512.512

Published: 2016

Journal Articles

HLA-C expression levels define permissible mismatches in hematopoietic cell transplantation

Blood (2014) 124 (26): 3996–4003.

https://doi.org/10.1182/blood-2014-09-599969

Published: 2014

Includes: Supplemental data

Journal Articles

GVHD prophylaxis made safe, easy, and inexpensive

Olle Ringdén

Blood (2014) 124 (25): 3672–3673.

https://doi.org/10.1182/blood-2014-10-607879

Published: 2014

Journal Articles

Survival after T-Cell Replete Haplo-Identical Related Donor Transplant Using Post-Transplant Cyclophosphamide Compared with Matched Unrelated Donor Transplant for Acute Myeloid Leukemia

Blood (2014) 124 (21): 679.

https://doi.org/10.1182/blood.V124.21.679.679

Published: 2014

Journal Articles

Pre-Transplant C-Reactive Protein (CRP), Ferritin and Albumin As Biomarkers to Predict Transplant Related Mortality (TRM) after Allogeneic Hematopoietic Cell Transplant (HCT)

Andrew S. Artz, MD MS, Brent R. Logan, PhD, Xiaochun Zhu, MS, Görgün Akpek, MD MHS, Rodrigo Martino, MD PhD, Vikas Gupta, MD FRCP, FRCPath, Hillard M. Lazarus, MD, Mark R. Litzow, MD, Alison Wakoff Loren, MD MS, Navneet S. Majhail, MD MS, Richard T. Maziarz, MD, Philip L. McCarthy, MD, Uday R. Popat, MD, Wael Saber, MD MS, Stephen R. Spellman, MBS, Olle Ringdén, MDPhD, Kenneth R. Cooke, MD, Marcelo C. Pasquini, MD MS

Blood (2014) 124 (21): 422.

https://doi.org/10.1182/blood.V124.21.422.422

Published: 2014

Journal Articles

Human C1q Deficiency and Allogeneic Hematopoietic Stem Cell Transplantation

Richard Olsson, MD PhD, Olle Ringden, MD PhD, Lennart Truedsson, MD PhD, Anders Åhlin, MD PhD

Blood (2014) 124 (21): 5922.

https://doi.org/10.1182/blood.V124.21.5922.5922

Published: 2014

Journal Articles

Amino acid substitution at peptide-binding pockets of HLA class I molecules increases risk of severe acute GVHD and mortality

Blood (2013) 122 (22): 3651–3658.

https://doi.org/10.1182/blood-2013-05-501510

Published: 2013

Includes: Supplemental data

Journal Articles

Graft Failure In Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation

Richard Olsson, MD, PhD, Daniel Moreno Berggren, MD, Olle Ringden, MD, PhD, Jonas Mattsson, MD, PhD, Mats Remberger, PhD

Blood (2013) 122 (21): 4559.

https://doi.org/10.1182/blood.V122.21.4559.4559

Published: 2013

Journal Articles

Low CD34 Cell Dose Is Associated With Higher Non-Relapse and Overall Mortality After Reduced Intensity Conditioning Hematopoietic Cell Transplantation For Acute Myeloid Leukemia and Myelodysplastic Syndrome

Johan Thörlén, MD, Olle Ringdén, MD, PhD, Jennifer Le Rademacher, PhD, Minoo Battiwalla, MD, MS, Junfang Chen, MS, Vincent T. Ho, MD, Partow Kebriaei, MD, Carolyn A. Keever-Taylor, PhD, Tamila L. Kindwall-Keller, DO, Hillard M. Lazarus, MD, Mary J. Laughlin, MD, Michael Lill, MD, BS, Tracey A. O’Brien, FRACP, MBChB, MHL, BSc, Miguel Angel Perales, MD, Vanderson Rocha, MD, PhD, Bipin N. Savani, MD, David Szwajcer, MD, FRCPC, David Valcarcel, MD, Mary Eapen, MBBS, MS

Blood (2013) 122 (21): 3342.

https://doi.org/10.1182/blood.V122.21.3342.3342

Published: 2013

Journal Articles

Identification Of Patients At High Risk Of Chronic Graft-Versus-Host Disease: Gvhd Prophylaxis

Gabriel Afram, MD, Jose Antonio Pérez Simón, MD, PhD, Mats Remberger, PhD, Teresa Caballero-Velázquez, MD, PhD, Rodrigo Martino, MD, PhD, Jose Luis Piñana, MD, Olle Ringden, MD, Albert Esquirol, MD, Dolores Caballero, MD, PhD, Irene Garcia, MD, Lucía López-Corral, MD, PhD, Jordi Sierra, Oriana López-Godino, Per T. Ljungman, MD, PhD, Jesus F San Miguel, MD, PhD, Hans Hagglund, MD PhD

Blood (2013) 122 (21): 4611.

https://doi.org/10.1182/blood.V122.21.4611.4611

Published: 2013

Journal Articles

Amino Acid Substitution At Peptide-Binding Pockets of HLA Class I Molecules Adversely Impacts Hematopoietic Cell Transplantation Outcomes

Blood (2012) 120 (21): 467.

https://doi.org/10.1182/blood.V120.21.467.467

Published: 2012

Journal Articles

Sequential Chemotherapy Followed by Reduced Intensity Conditioning and Allogeneic Stem Cell Transplantation (allo-SCT) in Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML): A Survey From the Acute Leukemia Working Party of EBMT

Olle Ringden, MD PhD, Myriam Labopin, Hans Jochem Kolb, MD, Mauricette Michallet, MD, PhD, Nicolaus Kröger, Arnold Ganser, Donald Bunjes, Michael Hallek, MD, Lothar Kanz, MD, Rainer Schwerdtfeger, Ernst Holler, MD, Renate Arnold, MD, Anne Huynh, MD, Arnon Nagler, MD, Christoph Schmid, MD, PhD, Mohamad Mohty

Blood (2012) 120 (21): 2025.

https://doi.org/10.1182/blood.V120.21.2025.2025

Published: 2012

Journal Articles

Improved Survival with Ursodeoxycholic Acid Prophylaxis in Allogeneic Stem Cell Transplantation: Long-Term Follow-up of a Randomized Study of the Nordic Bone Marrow Transplantation Group

Tapani Ruutu, MD PhD, Eeva Juvonen, MD PhD, Mats Remberger, MD PhD, Kari Remes, MD PhD, Liisa Volin, Jonas Mattsson, MD PhD, Anne Nihtinen, MD, Hans Hagglund, MD PhD, Olle Ringden, MD PhD

Blood (2011) 118 (21): 488.

https://doi.org/10.1182/blood.V118.21.488.488

Published: 2011

Journal Articles

Spleen Status and Engraftment After Allogeneic Hematopoietic Stem Cell Transplantation (HCT).

Blood (2010) 116 (21): 3486.

https://doi.org/10.1182/blood.V116.21.3486.3486

Published: 2010

Journal Articles

Early Intervention with Mesenchymal Stromal Cells for Refractory Grade III-IV Graft Versus Host Disease In Children Results In Excellent Long Term Outcome

Lynne Margaret Ball, MD, PhD, Maria E. Bernardo, MD, PhD, Jaap Jan Zwaginga, MD, PhD, Maarten van Tol, PhD, Angela Cometa, Helene Roelofs, PhD, Giovanna Giorgiani, Cornelia M Jol-van der Zijde, PhD, Maria Antonietta Avanzini, MD, Katarina Le Blanc, MD, PhD, Alice Bertaina, Francesco Frassoni, MD, Willem E. Fibbe, MD, PhD, Olle Ringden, MD, R. Maarten Egeler, MD, PhD, Franco Locatelli, MD, Arjan Lankester, MD, PhD

Blood (2010) 116 (21): 2336.

https://doi.org/10.1182/blood.V116.21.2336.2336

Published: 2010

Journal Articles

Outcomes of pediatric bone marrow transplantation for leukemia and myelodysplasia using matched sibling, mismatched related, or matched unrelated donors

Blood (2010) 116 (19): 4007–4015.

https://doi.org/10.1182/blood-2010-01-261958

Published: 2010

Includes: Supplemental data

Journal Articles

NK cells expressing inhibitory KIR for non–self-ligands remain tolerant in HLA-matched sibling stem cell transplantation

Andreas T. Björklund, Marie Schaffer, Cyril Fauriat, Olle Ringdén, Mats Remberger, Christina Hammarstedt, A. John Barrett, Per Ljungman, Hans-Gustaf Ljunggren, Karl-Johan Malmberg

Blood (2010) 115 (13): 2686–2694.

https://doi.org/10.1182/blood-2009-07-229740

Published: 2010

Journal Articles

Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplant (HSCT) for Myeloma (MM) - Chronic Graft Versus Host Disease (GVHD) is Associated with Lower Risk of Relapse and Superior Progression Free Survival (PFS) - A CIBMTR Analysis.

Parameswaran N Hari, MD, A. John Barrett, MD, Smriti Shrestha, MS, MA, Gisela Tunes da Silva, PhD, Mei-Jie Zhang, PhD, Angela Dispenzieri, MD, Gustavo A. Milone, MD, Sagar Lonial, MD, Olle Ringden, MD

Blood (2009) 114 (22): 53.

https://doi.org/10.1182/blood.V114.22.53.53

Published: 2009

NARROW

Decidua Stromal Cell (DSCs), As an Alternative Treatment for Acute Inflammatory Diseases

The Use of Placenta-Derived Decidua Stromal Cells for Treatment of Severe Acute Gastrointestinal Graft-Versus-Host-Disease in Adults and Children

Comparable Results of Autologous and Allogeneic Hematopoietic Stem Cell Transplantation for Adult Patients with Philadelphia-Positive Acute Lymphoblastic Leukemia in First Complete Molecular Remission: An Analysis By the Acute Leukemia Working Party of the EBMT

HLA-C expression levels define permissible mismatches in hematopoietic cell transplantation

GVHD prophylaxis made safe, easy, and inexpensive

Survival after T-Cell Replete Haplo-Identical Related Donor Transplant Using Post-Transplant Cyclophosphamide Compared with Matched Unrelated Donor Transplant for Acute Myeloid Leukemia

Pre-Transplant C-Reactive Protein (CRP), Ferritin and Albumin As Biomarkers to Predict Transplant Related Mortality (TRM) after Allogeneic Hematopoietic Cell Transplant (HCT)

Human C1q Deficiency and Allogeneic Hematopoietic Stem Cell Transplantation

Amino acid substitution at peptide-binding pockets of HLA class I molecules increases risk of severe acute GVHD and mortality

Graft Failure In Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation

Low CD34 Cell Dose Is Associated With Higher Non-Relapse and Overall Mortality After Reduced Intensity Conditioning Hematopoietic Cell Transplantation For Acute Myeloid Leukemia and Myelodysplastic Syndrome

Identification Of Patients At High Risk Of Chronic Graft-Versus-Host Disease: Gvhd Prophylaxis

Amino Acid Substitution At Peptide-Binding Pockets of HLA Class I Molecules Adversely Impacts Hematopoietic Cell Transplantation Outcomes

Sequential Chemotherapy Followed by Reduced Intensity Conditioning and Allogeneic Stem Cell Transplantation (allo-SCT) in Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML): A Survey From the Acute Leukemia Working Party of EBMT

Improved Survival with Ursodeoxycholic Acid Prophylaxis in Allogeneic Stem Cell Transplantation: Long-Term Follow-up of a Randomized Study of the Nordic Bone Marrow Transplantation Group

Spleen Status and Engraftment After Allogeneic Hematopoietic Stem Cell Transplantation (HCT).

Early Intervention with Mesenchymal Stromal Cells for Refractory Grade III-IV Graft Versus Host Disease In Children Results In Excellent Long Term Outcome

Outcomes of pediatric bone marrow transplantation for leukemia and myelodysplasia using matched sibling, mismatched related, or matched unrelated donors

NK cells expressing inhibitory KIR for non–self-ligands remain tolerant in HLA-matched sibling stem cell transplantation

Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplant (HSCT) for Myeloma (MM) - Chronic Graft Versus Host Disease (GVHD) is Associated with Lower Risk of Relapse and Superior Progression Free Survival (PFS) - A CIBMTR Analysis.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only